Prestigious Recognitions, Tender Offer Results, Clinical Trials, Annual Summits and Strategic Acquisitions - Research Report on Cerner, WebMD, Medidata, MedAssets and Quality Systems

NEW YORK, October 2, 2013 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

Today, Analysts' Corner announced new research reports highlighting Cerner Corporation (NASDAQ: CERN), WebMD Health Corp. (NASDAQ: WBMD), Medidata Solutions, Inc. (NASDAQ: MDSO), MedAssets, Inc. (NASDAQ: MDAS) and Quality Systems Inc. (NASDAQ: QSII). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Cerner Corporation Research Report

On September 19, 2013, Cerner Corp. (Cerner) announced the successful inclusion of the Company into the 2013 InformationWeek 500, a list of the top technology innovators in the U.S. The Company ranked no. 69 and marked its first ever entry into the list. Commenting on this recognition, Bill Graff, Senior Vice President of Cerner's Technology Services Organization said, "We are very pleased to have Cerner recognized by InformationWeek for our innovative use of technology, and we thank our clients for all of their support as we continue to pursue new innovations on their behalf." Cerner also reported that it has recently been recognized by Forbes as the 7^th most innovative Company in America and 13^th most innovative Company worldwide. The Full Research Report on Cerner Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/83ac_CERN]

--

WebMD Health Corp. Research Report

On September 16, 2013, WebMD Health Corp. (WebMD) announced the final results of its tender offer to purchase up to 5.0 million shares of its Common Stock, which expired at 5:00 p.m., New York City time, on September 10, 2013. The Company reported that it has accepted for purchase 5.0 million shares of its Common Stock, including all odd lots properly tendered, at a purchase price of $34.00 per share, for an aggregate purchase price of $170 million. Immediately following the purchase of the tendered shares, WebMD expects to have approximately 45.8 million shares of its Common Stock outstanding and to have approximately $880 million in cash and cash equivalents. The Full Research Report on WebMD Health Corp. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/c4b8_WBMD]

--

Medidata Solutions, Inc. Research Report

On September 19, 2013, Medidata Solutions (Medidata) announced the sponsorship of its first clinical trial, evaluating the impact of mobile and cloud-based technology on patient engagement for improved health outcomes in the diabetes community. According to Medidata, the pioneering study will test whether technology can improve the rates of therapy adoption and drive better outcomes for people with diabetes. "We are proud to sponsor our first clinical study in collaboration with Spaulding and Withings to see how disruptive technology can improve patient engagement and actually lead to better medical outcomes," said Glen de Vries, President of Medidata Solutions. "Since our beginning, Medidata has pioneered the use of technology to transform clinical research, and the opportunity to see our technology used to improve patient health in the critical area of diabetes care is a logical-and incredibly exciting-extension." The Full Research Report on Medidata Solutions, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/05dd_MDSO]

--

MedAssets, Inc. Research Report

On September 5, 2013, MedAssets, Inc. (MedAssets) announced the opening for the call for speakers for the 2014 Healthcare Business Summit, an annual convergence of more than 4,000 industry leaders designed to promote networking, collaboration and education initiatives applicable to today's healthcare environment. The Company informed that the Education Sessions will be held on Wednesday, April 23, 2014 at the Mandalay Bay Convention Center in Las Vegas. Nationally-recognized and professional speakers, third-party consultants and MedAssets clients have been invited to submit an application to share key strategies and experiences in support of improving the nation's healthcare system and providers' communities. The Company informed that the deadline for submissions is October 31, 2013. The Full Research Report on MedAssets, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/0913_MDAS]

--

Quality Systems Inc. Research Report

On September 9, 2013, Quality Systems Inc. (Quality Systems) announced its acquisition of Mirth Corp., a global leader in health information technology that helps clients achieve interoperability. According to the Company, the acquisition enhances its current enterprise interoperability initiatives and broadens its accountable and collaborative care, population health, disease management and clinical data exchange offerings. "Mirth's reputation as one of the most adopted, open, and globally trusted interconnectivity platforms is a natural fit for NextGen's established network of providers," said Steve Puckett, Chief Technology Officer for Quality Systems, Inc. "By bringing our companies together we can quickly bring to market an unprecedented level of data exchange that will allow patients, providers and healthcare facilities to participate fully in a collaborative and connected care environment." The Full Research Report on Quality Systems Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/d96f_QSII]

----

EDITOR NOTES:

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts' Corner